Active participation in international conferences and symposiums (59)
  1. 9. Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Slegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2021). Picalm reduction exacerbates tau pathology in a murine tauopathy model. (p. 77, Poster 04) Abstract session presented at  New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
  2. 10. Ando, K., Ndjim, M., Turbant, S., Fontaine, G., Pregoni, G., Dauphinot, L., Suain, V., Mansour, S., Authelet, M., De Decker, R., Delatour, B., Brain Bank NeuroCEB Neuropathology Network,, Duyckaerts, C., Leroy, K., Potier, M.-C., & Brion, J. P. (2021). The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease. (p. 60) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26, 2021: Lille, France).
  3. 11. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 72) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  4. 12. Doeraene, E., Erneux, C., Yilmaz, Z., Mansour, S., Suain, V., Turbant, S., Duyckaerts, C., Brain Bank NeuroCEB Neuropathology Network,, Schurmans, S., Brion, J. P., Leroy, K., & Ando, K. (2021). Protein level and solubility of the PI 5-phosphatase SHIP2 is altered in correlation with Amyloid pathology in Alzheimer’s brains. (p. 75) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  5. 13. López Gutiérrez, L., Kosa, A.-C., De Decker, R., Yilmaz, Z., Suain, V., Brion, J. P., Ando, K., & Leroy, K. (2021). Comparison of tau seeding activities between Alzheimer disease and FTLD- MAPT-G335A mutation. (p. 96) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  6. 14. López Gutiérrez, L., Kosa, A.-C., De Decker, R., Yilmaz, Z., Suain, V., Brion, J. P., Ando, K., & Leroy, K. (2021). Comparison of tau seeding activities between Alzheimer disease and FTLD-MAPT-G335A mutation. (p. 136) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
  7. 15. Kosa, A.-C., Ando, K., Lasri, H., Yilmaz, Z., Doeraene, E., López Gutiérrez, L., De Decker, R., De Fisenne, M.-A., Suain, V., Buée, L., Brion, J. P., & Leroy, K. (2021). Deletion of murine APP accelerates cognitive deficits in a murine model of amyloid and tau pathologies. (p. 88) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  8. 16. Brion, J. P. (2020). Maladie d'Alzheimer: aspects historiques et défis actuels de la recherche. Paper session presented at Journée Scientifique Francophone du CALM (Club Alzheimer de Montpellier) (WEB-Conference: 17 et 18/11 2020: Montpellier).
  9. 17. Brion, J. P. (2020). Tau Research: History and Current Challenges: Plenary Lecture. Paper session presented at Tau2020 Global Conference. (Organized by the Rainwater Foundation, CurePSP, and the Alzheimer Association (USA): Feb 12-13, 2020: Washington,DC, USA).
  10. 18. Pierrot, N., Ris, L., Stancu, I.-C., Doshina, A., Ribeiro, F., Tyteca, D., Bauge, E., Lalloyer, F., Malong, L., Schakman, O., Leroy, K., Kienlen-Campard, P. K., Gailly, P., Brion, J. P., Dewachter, I., Staels, B., & Octave, J. N. (2019). Gender specific improvement of synaptic function by activation of RXR nuclear receptor is mediated by PPAR alpha. Paper session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD) (26-31 march 2019: Lisbon, Portugal).
  11. 19. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Mansour, S., Boom, A., Ando, K., Brion, J. P., & Leroy, K. (2019). Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo through p25/CDK5 activation. Paper session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD) (26-31 march 2019: Lisbon, Portugal).
  12. 20. Poncelet, L., Ando, K., Vergara Panos, C., Gilissen, E., Yilmaz, Z., Mansour, S., Brion, J. P., & Leroy, K. (2019). Aged cats: a naturally occuring model of tauopathy. Abstract session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD)(26-31 march 2019: Lisbon, Portugal)
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Next >>